936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120)
    Meeting Abstract

    Schindler, K.; Abraham, R.; Shah, P. D.; Chandarlapaty, S.; Paik, P. K.; Bell-Mcguinn, K.; Bajorin, D. F.; Mellinghoff, I. K.; Younes, A.; Gounder, M. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas
    Meeting Abstract

    Gounder, M. M.; Loong, H. H. F.; Nyquist-Schultz, K.; Baker, S.; Ustoyev, Y.; Tanner, L. R.; Shacham, S.; McCauley, D.; Rashal, T.; Saint-Martin, J. R.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alliance A091102: Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma
    Meeting Abstract

    Dickson, M. A.; Mahoney, M. R.; Tap, W. D.; D'Angelo, S. P.; Keohan, M. L.; Van Tine, B. A.; Agulnik, M.; Horvath, L. E.; Schwartz, G. K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Characterization of isolated, uncomplicated nentropenia-related to the CDK4/6 inhibitor palboriclib
    Meeting Abstract

    DeMichele, A.; Dickson, M. A.; Clark, A. S.; Colameco, C.; Gallagher, M.; Gramlich, K.; Zafman, K.; Lewis, D.; Langer, M.; Vaughn, D. J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Long-term disease control of advanced gastrointestinal stromal tumors (GIST) with imatinib (IM): 10-year outcomes from SWOG phase III intergroup trial S0033
    Meeting Abstract

    Demetri, G. D.; Rankin, C. J.; Benjamin, R. S.; Borden, E. C.; Ryan, C. W.; Priebat, D. A.; Tap, W. D.; von Mehren, M.; Blackstein, M. E.; Heinrich, M. C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • PD-LI expression and immune infiltrates in sarcoma
    Meeting Abstract

    D'Angelo, S. P.; Shoushtari, A. N.; Agaram, N. P.; Kuk, D.; Qin, L. X.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alliance A091103: A multicenter phase II study of the angiopoietin-1 and-2 peptibody trebananib (AMG386) for the treatment of angiosarcoma (AS)
    Meeting Abstract

    D'Angelo, S. P.; Mahoney, M. R.; Van Tine, B. A.; Adkins, D.; Perdekamp, M. T. G.; Condy, M. M.; Hartley, E. W.; Antonescu, C. R.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Targeting vascular endothelial growth factor A and tumor hypoxia combined with radiation eradicates sarcomas through destruction of tumor vasculature and thwarting of the hypoxic response
    Meeting Abstract

    Yoon, C.; Lee, H. J.; Park, D. J.; Tap, W. D.; Eisinger-Mathason, T. S. K.; Kirsch, D. G.; Simon, M. C.; Yoon, S. S.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Potent antitumor activity of MLN0128, an investigational selective mTORC1/2 kinase inhibitor, in preclinical models of rhabdomyosarcoma
    Meeting Abstract

    Slotkin, E.; Patwardhan, P.; Deraje, S. V. ; Schwartz, G.; Tap, W.
    Cancer Research (2014)

    Fulltext@MSK | Save
  • Dual lineage inhibition of ETV1 and KIT disrupts the ETV1-KIT feed forward circuit and potentiates imatinib antitumor effect in GIST oncogenesis
    Meeting Abstract

    Ran, L.; Sirota, I.; Cao, Z.; Murphy, D.; Shukla, S.; Rossi, F.; Wongvipat, J.; Tap, W. D.; Besmer, P.; Antonescu, C. R.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save